Knight Therapeutics | GUD - Ebit

Stock Price
7.73
Daily Change
0.28 3.76%
Monthly
24.68%
Yearly
35.85%
Q2 Forecast
7.26

Knight Therapeutics reported CAD6.21M in EBIT for its fiscal quarter ending in December of 2025.





Ebit Change Date
Acasti Pharma USD -3.7M 1.13M Dec/2024
Akebia Therapeutics USD -5.45M 9.4M Dec/2025
Alaunos Therapeutics USD -1.19M 148K Sep/2025
Aurora Cannabis CAD -35.79M 8.96M Dec/2025
Avita Medical AUD -10.39M 1.72M Dec/2025
Canopy Growth CAD -12.66M 1.64M Dec/2025
Cronos Group USD -7.06M 62.31M Dec/2025
Dianthus Therapeutics USD -69.54M 29.25M Dec/2025
Ionis Pharmaceuticals USD -215M 54.82M Dec/2025
IQVIA Holdings USD 2.68B 2.1B Dec/2025
Knight Therapeutics CAD 6.21M 3.27M Dec/2025
Moderna USD -857M 597M Dec/2025
Omeros USD -48.15M 7.25M Sep/2023
Organigram Holdings CAD -20.13M 7.92M Dec/2025
Organon & Co USD 388M 28M Sep/2025
Revvity USD 145.83M 47.49M Dec/2025
Tectonic Therapeutic USD -21.52M 374K Dec/2025
Tilray USD -20.01M 9.34M Sep/2025
Viatris USD -157.5M 392M Dec/2025
Xeris Pharmaceuticals USD 16.77M 8.88M Dec/2025